See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Ryan Zarychanski

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	38938844	0	Godoy LC, Neal MD, Goligher EC, et al. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Adv. 2024 Jan 26;3(3):100780. doi: 10.1016/j.jacadv.2023.100780. eCollection 2024 Mar.
	38830735	0	Houston BL, McIsaac DI, Breau RH, et al. Hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery (TRACTION): protocol for a phase IV randomised controlled trial. BMJ Open. 2024 Jun 3;14(6):e084847. doi: 10.1136/bmjopen-2024-084847.
	38548736	0	Tran A, Fernando SM, Rochwerg B, et al. Prognostic Factors Associated with Venous Thromboembolism Following Traumatic Injury: A Systematic Review and Meta-Analysis. J Trauma Acute Care Surg. 2024 Mar 29. doi: 10.1097/TA.0000000000004326.
	38503600	0	Schulman S, Arnold DM, Bradbury CA, et al. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2024 Mar 18:S1538-7836(24)00113-2. doi: 10.1016/j.jtha.2024.02.011.
	37854455	0	Walborn AT, Heath A, Neal MD, et al. Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial. Res Pract Thromb Haemost. 2023 Sep 16;7(7):102203. doi: 10.1016/j.rpth.2023.102203. eCollection 2023 Oct.
	37526722	0	Goligher EC, Lawler PR, Zarychanski R. Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply. JAMA. 2023 Aug 1;330(5):472-473. doi: 10.1001/jama.2023.9538.
	37227729	0	Berger JS, Neal MD, Kornblith LZ, et al. Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial. JAMA Netw Open. 2023 May 1;6(5):e2314428. doi: 10.1001/jamanetworkopen.2023.14428.
	36942550	0	Goligher EC, Lawler PR, Jensen TP, et al. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19. JAMA. 2023 Apr 4;329(13):1066-1077. doi: 10.1001/jama.2023.3651.
	35315874	0	Bradbury CA, Lawler PR, Stanworth SJ, et al. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2022 Apr 5;327(13):1247-1259. doi: 10.1001/jama.2022.2910.
	35226556	0	Lawler PR, Hochman JS, Zarychanski R. What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine? Circulation. 2022 Mar;145(9):629-632. doi: 10.1161/CIRCULATIONAHA.121.058113. Epub 2022 Feb 28.
	34788517	0	Zarychanski R, Lawler PR, Goligher E. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply. N Engl J Med. 2021 Nov 18;385(21):2014. doi: 10.1056/NEJMc2115560.
	34636806	0	Tran A, Fernando SM, Rochwerg B, et al. Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients-A Systematic Review and Meta-Analysis. Crit Care Med. 2021 Oct 12. pii: 00003246-900000000-95047. doi: 10.1097/CCM.0000000000005382.
	34351722	0	Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
	34351721	0	Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
	32888372	0	Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
	32816822	0	Godoy LC, Goligher EC, Lawler PR, et al. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19. CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16.
	32815416	0	Houston BL, Lawler PR, Goligher EC, et al. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.
	31982293	0	Houston BL, Uminski K, Mutter T, et al. Efficacy and Safety of Tranexamic Acid in Major Non-Cardiac Surgeries at High Risk for Transfusion: A Systematic Review and Meta-Analysis. Transfus Med Rev. 2020 Jan;34(1):51-62. doi: 10.1016/j.tmrv.2019.10.001. Epub 2019 Oct 23.
	31530593	0	Alaifan T, Alenazy A, Xiang Wang D, et al. Tranexamic acid in cardiac surgery: a systematic review and meta-analysis (protocol). BMJ Open. 2019 Sep 17;9(9):e028585. doi: 10.1136/bmjopen-2018-028585.
	30194674	0	Lodewyks C, Heinrichs J, Grocott HP, et al. Point-of-care viscoelastic hemostatic testing in cardiac surgery patients: a systematic review and meta-analysis. Can J Anaesth. 2018 Dec;65(12):1333-1347. doi: 10.1007/s12630-018-1217-9. Epub 2018 Sep 7.
	30046678	0	Arnold DM, Lauzier F, Albert M, et al. The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia. Res Pract Thromb Haemost. 2017 May 31;1(1):103-111. doi: 10.1002/rth2.12004. eCollection 2017 Jul.
	28160670	0	Coyle K, Carrier M, Lazo-Langner A, et al. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism. Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25.
	27405066	0	Gould TJ, Lysov Z, Swystun LL, et al. Extracellular Histones Increase Tissue Factor Activity and Enhance Thrombin Generation by Human Blood Monocytes. Shock. 2016 Dec;46(6):655-662. doi: 10.1097/SHK.0000000000000680.
	26817957	0	Ihaddadene R, Corsi DJ, Lazo-Langner A, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27.
	26095467	0	Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.
	25493972	0	Zarychanski R, Abou-Setta AM, Kanji S, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015 Mar;43(3):511-8. doi: 10.1097/CCM.0000000000000763.
	25474533	0	Lim W, Meade M, Lauzier F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713.